Metoclopramide Injection USP recall: Contamination
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)
Why was Metoclopramide Injection USP recalled?
Chemical contamination; Unknown brown residue adhering to the inside of one vial.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 31325335B, exp. date 07/2021
- Product
- Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)
- Recalling firm
- Teva Pharmaceuticals USA
- Quantity
- 9,452 cartons
- Distribution
- Nationwide, including Puerto Rico
- Recall date
- March 10, 2021
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)